AYTU vs SPCE · rev $66.4M vs rev $361.0K
Aytu BioScience Inc (AYTU) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
AYTU currently screens at market cap $24.1M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the AYTU and SPCE stock pages for the full models.
Not investment advice.